Skip to main content
Contact Us
Subscribe
E-Edition
39°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anavex Life Sciences Corp. - Common Stock
(NQ:
AVXL
)
8.520
+0.050 (+0.59%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Anavex Life Sciences Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
February 12, 2025
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Scheduled For February 12, 2025
February 12, 2025
Via
Benzinga
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz
January 14, 2025
The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.
Via
Stocktwits
10 Health Care Stocks With Whale Alerts In Today's Session
December 26, 2024
Via
Benzinga
Earnings Scheduled For December 23, 2024
December 23, 2024
Via
Benzinga
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday
December 26, 2024
Via
Benzinga
Short-Squeeze Target Anavex Life Sciences Gains Traction
December 26, 2024
Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more.
Via
MarketBeat
Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday
December 24, 2024
Via
Benzinga
Honda Motor, Rumble, Despegar.com And Other Big Stocks Moving Higher On Monday
December 23, 2024
Via
Benzinga
US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus
December 23, 2024
U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade.
Via
Benzinga
Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone
December 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday
December 23, 2024
Via
Benzinga
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
November 08, 2024
GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday. Here's a look at what's going on:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via
Benzinga
AVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q3 2024
August 06, 2024
AVXL stock results show that Anavex Life Sciences missed analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 29, 2024
Via
Benzinga
Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%
July 29, 2024
Anavex Life Sciences presented Phase 2b/3 study results at AAIC 2024, showing daily oral blarcamesine (ANAVEX2-73) significantly slows clinical decline in early Alzheimer's disease. The 48-week study...
Via
Benzinga
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 29, 2024
Via
Benzinga
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 16, 2024
Via
Benzinga
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 16, 2024
Via
Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm
May 13, 2024
From
Schall Law
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL)
May 10, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
AVXL Stockholders: Additional Lawsuit Filed Against Anavex Life Sciences Corporation; Contact Robbins LLP Regarding the May 13, 2024 Lead Plaintiff Deadline
May 09, 2024
From
Robbins LLP
Via
GlobeNewswire
AVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q2 2024
May 09, 2024
AVXL stock results show that Anavex Life Sciences missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ANAVEX ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm
May 08, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
May 08, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm
May 07, 2024
From
Schall Law
Via
GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
May 01, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.